Log in to save to my catalogue

Co-expression of galectin-3 and CRIP-1 in endometrial cancer: prognostic value and patient survival

Co-expression of galectin-3 and CRIP-1 in endometrial cancer: prognostic value and patient survival

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1752575106

Co-expression of galectin-3 and CRIP-1 in endometrial cancer: prognostic value and patient survival

About this item

Full title

Co-expression of galectin-3 and CRIP-1 in endometrial cancer: prognostic value and patient survival

Publisher

New York: Springer US

Journal title

Medical oncology (Northwood, London, England), 2016-01, Vol.33 (1), p.8, Article 8

Language

English

Formats

Publication information

Publisher

New York: Springer US

More information

Scope and Contents

Contents

Endometrial cancer is the sixth most common cancer in women. Galectin-3 (GAL-3) and CRIP-1 are multifunctional proteins which seem to be involved in many neoplasias. This study aims to point out correlations between clinicopathological findings and endometrial cancer patient survival to GAL-3 and CRIP-1 expression in order to enfold their diagnosti...

Alternative Titles

Full title

Co-expression of galectin-3 and CRIP-1 in endometrial cancer: prognostic value and patient survival

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_1752575106

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1752575106

Other Identifiers

ISSN

1357-0560

E-ISSN

1559-131X

DOI

10.1007/s12032-015-0723-7

How to access this item